NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

NeuroBo Pharmaceuticals Inc (NASDAQ: NRBO)

 
NRBO Technical Analysis
1
As on 6th Feb 2023 NRBO SHARE Price closed @ 0.83 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NRBOSHARE Price

Open 0.84 Change Price %
High 0.86 1 Day N/A N/A
Low 0.81 1 Week 0.00 0.00
Close 0.83 1 Month 0.00 0.00
Volume 1388793 1 Year 0.00 0.00
52 Week High 0.00 | 52 Week Low 0.00
 
NASDAQ USA Most Active Stocks
XELA 0.07 %
BBBY 5.86 %
FFIE 0.79 %
TSLA 194.76 %
AMZN 102.18 %
GOEV 1.09 %
SECO 3.77 %
AAPL 151.73 %
AMD 83.68 %
INTC 28.69 %
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
CREXW 0.02 100.00%
CRTDW 0.14 75.00%
ASPAW 0.10 66.67%
 
NASDAQ USA Top Losers Stocks
PTRAW 0.23 -89.59%
BIOTW 0.01 -87.50%
MILEW 0.06 -53.85%
ALACW 0.01 -50.00%
BTAQW 0.01 -50.00%
ALF 0.01 -50.00%
ALF 0.01 -50.00%
LOTZW 0.01 -50.00%
IGNY 6.98 -46.51%
IGNYW 0.17 -45.16%
 
 
NRBO
Daily Charts
NRBO
Intraday Charts
Whats New @
Bazaartrend
NRBO
Free Analysis
 
NRBO Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
 
NRBO Forecast February 2023
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
NRBO Weekly Forecast
4th UP Forecast0.00
3rd UP Forecast0.00
2nd UP Forecast0.00
1st UP Forecast0.00
1st DOWN Forecast0.00
2nd DOWN Forecast0.00
3rd DOWN Forecast0.00
4th DOWN Forecast0.00
 
NRBO Forecast2023
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
 
NRBO Other Details
Segment EQ
Market Capital 47601828.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NRBO Address
NRBO
 
NRBO Latest News
 
Your Comments and Response on NeuroBo Pharmaceuticals Inc
 
NRBO Business Profile
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for coronavirus, neurodegenerative, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which has completed Phase 2 clinical trial to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of protein; and Gemcabene, an acute indication for COVID-19. NeuroBo Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Boston, Massachusetts. Address: 200 Berkeley Street, Boston, MA, United States, 02116
 
2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service